Document ID: chunk:federal_register_of_legislation:F2025L00062:schedule:1:p31
Version: federal_register_of_legislation:F2025L00062
Segment Type: schedule
Provision Reference: sch 1 (pt 31/51)
Character Range: 94347–98206

10  0                        10
Oxycodone  Capsule containing oxycodone hydrochloride 5 mg  Oral  OxyNorm        MF  PDP       C10766                P10766                10  0                        10
Oxycodone  Capsule containing oxycodone hydrochloride 5 mg  Oral  OxyNorm        MF  PDP       C10768                P10768                20  0                        20
Oxycodone  Capsule containing oxycodone hydrochloride 5 mg  Oral  OxyNorm        MF  MP NP     C10764 C10771 C10772  P10764 P10771 P10772  20  0  V10764 V10771 V10772  20

[137] Schedule 1, Part 1, entries for Oxycodone in the form Tablet containing oxycodone hydrochloride 5 mg
substitute:
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  ENDONE                     AF  MP NP MW  C16276                P16276                10  0                        10
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  ENDONE                     AF  PDP       C10766                P10766                10  0                        10
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  ENDONE                     AF  MP NP     C10764 C10771 C10772  P10764 P10771 P10772  20  0  V10764 V10771 V10772  20
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  ENDONE                     AF  PDP       C10768                P10768                20  0                        20
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  Mayne Pharma Oxycodone IR  SZ  MP NP     C10764 C10771 C10772                        20  0  V10764 V10771 V10772  20
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  Mayne Pharma Oxycodone IR  SZ  PDP       C10768                                      20  0                        20
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  Oxycodone Viatris          MQ  MP NP MW  C16276                P16276                10  0                        10
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  Oxycodone Viatris          MQ  PDP       C10766                P10766                10  0                        10
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  Oxycodone Viatris          MQ  MP NP     C10764 C10771 C10772  P10764 P10771 P10772  20  0  V10764 V10771 V10772  20
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  Oxycodone Viatris          MQ  PDP       C10768                P10768                20  0                        20
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  Oxyndone                   TX  MP NP     C10764 C10771 C10772                        20  0  V10764 V10771 V10772  20
Oxycodone  Tablet containing oxycodone hydrochloride 5 mg  Oral  Oxyndone                   TX  PDP       C10768                                      20  0                        20

[138] Schedule 1, Part 1, entries for Paclitaxel, nanoparticle albumin-bound
substitute:
Paclitaxel, nanoparticle albumin-bound  Powder for I.V. injection containing 100 mg paclitaxel  Injection  Abraxane             TS  MP  C4657 C6106 C6119     See Note 3  See Note 3     1     D(100
Paclitaxel, nanoparticle albumin-bound  Powder for I.V. injection containing 100 mg paclitaxel  Injection  nab-PACLITAXEL JUNO  JU  MP  C4657 C6106 C6119     See Note 3  See Note 3     1     D(100)

[139] Schedule 1, Part 1, entries for Pembrolizumab
substitute:
Pembrolizumab  Solution concentrate for I.V. infusion 100 mg in 4 mL  Injection  Keytruda  MK  MP  C10676 C10688 C10701 C10705 C13432 C13437 C13726 C13727 C13728 C13730 C13731 C13732 C13735 C13736 C13739 C13741 C13948 C13949 C14027 C14044 C14324 C14403 C14404 C14727 C14770 C14786 C14817 C14818 C16264 C16280     See Note 3  See Note 3     1     D(100)

[140] Schedule 1, Part 1, after entry for Pirfenidone in the form Tablet 801mg [Brand: Pirfenidone Sandoz]